<?xml version='1.0' encoding='utf-8'?>
<document id="25495096"><sentence text="Synergistic Effect of Curcumin in Combination with Anticancer Agents in Human Retinoblastoma Cancer Cell Lines."><entity charOffset="22-30" id="DDI-PubMed.25495096.s1.e0" text="Curcumin" /></sentence><sentence text="Curcumin (diferuloylmethane), a phenolic compound obtained from the rhizome of the herb Curcuma longa, is known to have anti-proliferative and anti-tumor properties"><entity charOffset="0-8" id="DDI-PubMed.25495096.s2.e0" text="Curcumin" /><entity charOffset="10-27" id="DDI-PubMed.25495096.s2.e1" text="diferuloylmethane" /><entity charOffset="32-40" id="DDI-PubMed.25495096.s2.e2" text="phenolic" /><pair ddi="false" e1="DDI-PubMed.25495096.s2.e0" e2="DDI-PubMed.25495096.s2.e0" /><pair ddi="false" e1="DDI-PubMed.25495096.s2.e0" e2="DDI-PubMed.25495096.s2.e1" /><pair ddi="false" e1="DDI-PubMed.25495096.s2.e0" e2="DDI-PubMed.25495096.s2.e2" /><pair ddi="false" e1="DDI-PubMed.25495096.s2.e1" e2="DDI-PubMed.25495096.s2.e1" /><pair ddi="false" e1="DDI-PubMed.25495096.s2.e1" e2="DDI-PubMed.25495096.s2.e2" /></sentence><sentence text=" In this study, we evaluated the cytotoxic effect of curcumin alone and in combination with individual drugs like carboplatin, etoposide, or vincristine in a human retinoblastoma (RB) cancer cell line"><entity charOffset="53-61" id="DDI-PubMed.25495096.s3.e0" text="curcumin" /><entity charOffset="114-125" id="DDI-PubMed.25495096.s3.e1" text="carboplatin" /><entity charOffset="127-136" id="DDI-PubMed.25495096.s3.e2" text="etoposide" /><entity charOffset="141-152" id="DDI-PubMed.25495096.s3.e3" text="vincristine" /><pair ddi="false" e1="DDI-PubMed.25495096.s3.e0" e2="DDI-PubMed.25495096.s3.e0" /><pair ddi="false" e1="DDI-PubMed.25495096.s3.e0" e2="DDI-PubMed.25495096.s3.e1" /><pair ddi="false" e1="DDI-PubMed.25495096.s3.e0" e2="DDI-PubMed.25495096.s3.e2" /><pair ddi="false" e1="DDI-PubMed.25495096.s3.e0" e2="DDI-PubMed.25495096.s3.e3" /><pair ddi="false" e1="DDI-PubMed.25495096.s3.e1" e2="DDI-PubMed.25495096.s3.e1" /><pair ddi="false" e1="DDI-PubMed.25495096.s3.e1" e2="DDI-PubMed.25495096.s3.e2" /><pair ddi="false" e1="DDI-PubMed.25495096.s3.e1" e2="DDI-PubMed.25495096.s3.e3" /><pair ddi="false" e1="DDI-PubMed.25495096.s3.e2" e2="DDI-PubMed.25495096.s3.e2" /><pair ddi="false" e1="DDI-PubMed.25495096.s3.e2" e2="DDI-PubMed.25495096.s3.e3" /></sentence><sentence text="" /><sentence text="A drug-drug interaction was analyzed using the median effect/isobologram method and combination index values were used to characterize the interaction as synergistic or additive" /><sentence text=" We also performed the apoptosis and cell-cycle kinetics study with single drugs in combination with curcumin in a human RB cell lines (Y79 and Weri-Rb1)"><entity charOffset="101-109" id="DDI-PubMed.25495096.s6.e0" text="curcumin" /></sentence><sentence text="" /><sentence text="Curcumin caused concentration-dependent decrease in cell proliferation, cell kinetics, and also induced apoptosis in both the RB cell lines"><entity charOffset="0-8" id="DDI-PubMed.25495096.s8.e0" text="Curcumin" /></sentence><sentence text=" When combination of curcumin with individual drugs like carboplatin or etoposide or vincristine was treated on to RB cells, both cell viability and cell cycling were reduced and increased apoptosis was noted, in comparison with single drug treatment"><entity charOffset="21-29" id="DDI-PubMed.25495096.s9.e0" text="curcumin" /><entity charOffset="57-68" id="DDI-PubMed.25495096.s9.e1" text="carboplatin" /><entity charOffset="72-81" id="DDI-PubMed.25495096.s9.e2" text="etoposide" /><entity charOffset="85-96" id="DDI-PubMed.25495096.s9.e3" text="vincristine" /><pair ddi="false" e1="DDI-PubMed.25495096.s9.e0" e2="DDI-PubMed.25495096.s9.e0" /><pair ddi="false" e1="DDI-PubMed.25495096.s9.e0" e2="DDI-PubMed.25495096.s9.e1" /><pair ddi="false" e1="DDI-PubMed.25495096.s9.e0" e2="DDI-PubMed.25495096.s9.e2" /><pair ddi="false" e1="DDI-PubMed.25495096.s9.e0" e2="DDI-PubMed.25495096.s9.e3" /><pair ddi="false" e1="DDI-PubMed.25495096.s9.e1" e2="DDI-PubMed.25495096.s9.e1" /><pair ddi="false" e1="DDI-PubMed.25495096.s9.e1" e2="DDI-PubMed.25495096.s9.e2" /><pair ddi="false" e1="DDI-PubMed.25495096.s9.e1" e2="DDI-PubMed.25495096.s9.e3" /><pair ddi="false" e1="DDI-PubMed.25495096.s9.e2" e2="DDI-PubMed.25495096.s9.e2" /><pair ddi="false" e1="DDI-PubMed.25495096.s9.e2" e2="DDI-PubMed.25495096.s9.e3" /></sentence><sentence text=" These effects were significant in both the cell lines, indicating the ability of curcumin to increase the sensitivity of RB cells to chemotherapy drugs"><entity charOffset="82-90" id="DDI-PubMed.25495096.s10.e0" text="curcumin" /></sentence><sentence text="" /><sentence text="Our in vitro findings showed that the combination of curcumin with single drug treatment showed marked synergistic inhibitory effect against RB cell lines"><entity charOffset="53-61" id="DDI-PubMed.25495096.s12.e0" text="curcumin" /></sentence><sentence text=" These results suggest that curcumin can be used as a modulator which may have a potential therapeutic value for the treatment of RB cancer patients"><entity charOffset="28-36" id="DDI-PubMed.25495096.s13.e0" text="curcumin" /></sentence><sentence text="" /></document>